CAMRIA’s mission

Antimicrobial resistance (AMR) is one of the major threats to humanity and it has been estimated that, globally, AMR will cause 10 million deaths annually by 2050, a dramatic increase from the current 700.000 annual deaths from AMR-related infections. Of particular concern in Norway are the consequences of infections caused by antibiotic-resistant bacteria for cancer treatment, immune-based treatment, implant surgery, and intensive care. However, even minor surgery and common infections may become life threatening as the antibiotics that have been the cornerstone of modern medicine, are now losing effectiveness faster than they are being replaced with new antibiotics.

© Jørgen Barth

Systematic monitoring of AMR-spread is lacking in Norwegian hospitals - only when an outbreak is suspected, epidemiological investigations are undertaken. This highlights the importance of integrated stewardship in the usage of antibiotics. Institutional- and patient data are, presently, sparsely used to support AMR surveillance. This can be explained by scarce intersection between researchers and the practitioners, who could leverage the insights provided by tools targeting “precision medicine” interventions.

CAMRIA (Combatting Anti-Microbial Resistance with Interdisciplinary Approaches) Centre's goal is to use inter- and trans-disciplinary approaches to address these challenges in AMR research.

Our partners have competences in mathematics, microbiological diagnostics, bioinformatics, infection prevention and control, clinical infectious diseases, and social sciences. CAMRIA’s goal is to bring these disciplines together in one centre and to promote collaborative projects bridging the, currently limited, intersection of basal research projects and clinical studies. This will contribute to combating AMR challenges both in hospitals and in the society.

 

The CAMRIA centre aims at making a difference in 3 focus areas:

    • Optimising antimicrobial resistance (AMR) surveillance and integrated antibiotic stewardship.
    • Genomic AMR surveillance, using Klebsiella pneumoniae as a model organism.
    • Spanning both above areas and integrating social science approaches to gain knowledge about communication regarding AMR to prescribers, health care workers, patients and the general population.

 

 

CAMRIA Consortium

Leadership

The Centre's leadership consists of representatives of the three main institutions engaged in CAMRIA's research.

© Kommunikasjonsavdelingen, Stavanger Universitetssykehus
© Kommunikasjonsavdelingen ved Stavanger Universitetssykehus

Nina Langeland
CAMRIA Leader,
University of Bergen

© UiB
© UiB

Bjørn Blomberg
Haukeland University Hospital & University of Bergen

© Svein Lunde
© Svein Lunde

Iren Høyland Löhr
Stavanger University Hospital

Partners

Besides the leadership. the Consortium gathers researchers representing different fields that CAMRIA's research focuses on.

© David Gonzalez
© David Gonzalez

Guttorm Alendal
Department of Mathematics, UiB

© Eivind Senneset, UiB
© Eivind Senneset, UiB

Anne Lise Fimreite
Department of Government, UiB

 

© Øystein Rygg Haanæs
© Øystein Rygg Haanæs

Iain Johnston
Department of Mathematics, UiB

 

© Anders Bakke
© Anders Bakke

Eivind Valen
Institutt for informatikk,
Universitetet i Bergen